GI - nausea + vomit e-book Flashcards
Causes of nausea and vomiting
Postoperative nausea and vomiting (PONV)
Chemotherapy induced nausea and vomiting
Drug induced nausea and vomiting
Motion sickness
Pregnancy
Migraine
Palliative care
There are several classes of antiemetic drugs;
Antihistamines Dopamine antagonists Antimuscarinics 5HT3 antagonists Neurokinin receptor antagonists
Antihistamines e.g cyclizine, cinnarizine, promethazine
These are effective against nausea and vomiting resulting from many underlying conditions.
Side effects;
Drowsiness
Anticholinergic effects- blurred vision, constipation, dry mouth, urinary retention.
Angle-closure glaucoma
Bronchospasm
Cyclizine
forms, indication, dosage
Available for oral, intramuscular, intravenous or subcutaneous administration
Licensed indications
Motion sickness
Labyrinthine disorders
Nausea and vomiting of known cause
Nausea and vomiting associated with vestibular disorders
Palliative care
Dosage in adults; 50mg up to three times a day (for all routes of administration)
In palliative care a dose of 150mg can be given via subcutaneous infusion in a syringe driver over 24
hours.
Cinnarizine
forms, indication, dosage
Available orally only
Licensed indications
Relief ofsymptoms of vestibular disorders
Motion sickness
VD = Adults or children over 12 30mg three times daily MS = 30mg initially 2 hours before travel and then 15mg every 8 hours if required, dose to be taken during travel
Promethazine
forms, indication, dosage
Available orally only
Licensed indications
Labyrinthine disorders
Motion sickness
MS = 25mg daily LD = 25-75mg daily, max 100mg daily
Dopamine antagonists- phenothiazines, domperidoneand metoclopramide
Phenothiazines, e.g. prochlorperazine, perphenazine, trifluoperazine
Act centrally on the chemoreceptor trigger zone, these drugs are useful for the treatment of N&V
associated with diffuse neoplastic disease, radiation sickness, and emesis caused by drugs such as
opioids, general anaesthetics, and cytotoxics.
Side effects;
Dystonic reactions-resulting from Dopamine antagonism
Hypotension
Respiratory depression in susceptible patients
Sedation
Prochlorperazine
forms, indication, dosage
Available for oral, buccal, intramuscular
Licensed indications
Acute attack of nausea and vomiting: Initially 20mg then 10mg after 2 hours. IM 12.5mg as required to be followed by an oral dose after 6h if required
Prevention of nausea and vomiting: 5-10mg 2-3 times daily. IM 12.5mg as required to be followed by an oral dose after 6h if required
Labyrinthine disorders: 5mg 3 times a day increased to 30mg daily in divided doses
Nausea and vomiting in previously diagnosed migraine: 3-6mg bd (bucal tab)
Perphenazine
forms, indication, dosage
Only licensed for severe nausea and vomiting unresponsive to other antiemetics.
initially 4mg 3 times a day, max 24mg daily
elderly: initially 1-2mg 3 times a day, max 12mg daily
Trifluoperazine
forms, indication, dosage
Only licensed for severe nausea and vomiting
Note- perphenazine and trifluoperazine are not commonly used in the management of nausea and
vomiting.
severe nausea and vomit: 2-4mg in daily divided doses, 6mg max daily
Domperidone
forms, indication, dosage
Only licensed for the relief of nausea and vomiting.
Contraindicated in patients with cardiac disease.
Domperidone used to be very widely used however after the benefits and risks of domperidone were
reviewed the MHRA/CHMproduced the following advice as it was found to be associated with a small
increased risk of serious cardiac side effects.
Domperidone should only be used for the relief of the symptoms of nausea and vomiting;
Domperidone should be used at the lowest effective dose for the shortest possible duration
(max. treatment duration should not normally exceed 1 week);
Domperidone is contra-indicated for use in conditions where cardiac conduction is, or could be impaired, or where there is underlying cardiac disease, when administered concomitantly with
drugs that prolong the QT interval or potent CYP3A4 inhibitors, and in severe hepatic
impairment
However, note that this guidance does not apply to unlicensed uses of domperidone, e.g. in palliative
care.
dosage = Adult >35kg - 10mg up to 3 times daily, 30mg max
Child up to 35kg - 250micrograms/kg up to 3 times, max 750mcg/kg
Metoclopramide
forms, indication, dosage
Available for oral, intramuscular, intravenous or subcutaneous administration
Licensed indications
Symptomatic treatment of nausea and vomiting
Nausea and vomiting associated with acute migraine
Chemotherapy induced nausea and vomiting
Post-operative nausea and vomiting
Metoclopramide used to be widely used however after the benefits and risks of its use were reviewed
the MHRA/CSM produced the following guidance after it was found that the risk of neurological effects
such as extrapyramidal disorders and tardive dyskinesia outweigh the benefits in long term o high dose
treatment. To help minimise the risk of potentially serious neurological adverse effects the following
restrictions apply;
in adults over 18 years, metoclopramide should only be used for prevention of postoperative
nausea and vomiting, radiotherapy-induced nausea and vomiting, delayed (but not acute)
chemotherapy-induced nausea and vomiting, and symptomatic treatment of nausea and vomiting, including that associated with acute migraine (where it may also be used to improve
absorption of oral analgesics)
Metoclopramide should only be prescribed for short-term use (up to 5 days)
However, note that this guidance does not apply to unlicensed uses of metoclopramide, e.g. in palliative
care.
dosage: adult up to 60kg - up to 500mcg/kg daily in 3 divided doses given over atleast 3 min
>60kg - 10mg up to 3 times daily given over atleast 3 min
N+V in PC = 10mg 3 times daily, s/c 30-100mg/24 hours
Antimuscarinic- Hyoscine hydrobromide
forms, indication, dosage
Available for oral or transdermal administration
Only licensed for motion sickness (has other licensed indications not related to nausea and vomiting).
Can be bought OTC for the management of motion sickness.
Side effects;
Drowsiness
Anticholinergic syndrome
Dosage: 150-300mcg 30 mins before strat of journey then 150-300mcg every 6 hours if required, max 900mcg per day
5HT3 antagonists e.g. Ondansetron, granisteron, palonosetron
5HT3 antagonists block the 5HT3 receptors in the gastrointestinal tract and in the CNS. Side effects Constipation Diarrhoea Headache Insomnia
Ondansetron
forms, indication, dosage
Available for oral, intravenous and rectal administration.
Licensed indications;
Moderately emetogenic chemotherapy or radiotherapy
Severely emetogenic chemotherapy
Prevention of PONV
Treatment of PONV
Dosage: Initially 8mg 1-2 hours before treatment then 8mg every 12 hours for up to 5 days
Contraindicated in patients with congenital long QT syndrome